CEACAM5 and cancer: Utilizing the optimized process, a range of proteins have been tested, including SARS-CoV-2 N-Protein, PCT as a sepsis biomarker, PSA and CEA for cancer diagnosis (Fig. 3e and Figure S6), and pure buffer with no biomarkers as a control test.